| SOPHIA GENETICS SF -,05 |
| Schweiz |
| Gesundheit |
| CH1125843347 / A3CVT8 |
| 90B (Frankfurt) / SOPH (NASDAQ) |
| FRA:90B, ETR:90B, 90B:GR, NASDAQ:SOPH |
| - |
| https://www.sophiagenetic.. |
|
Sophia Genetics SA is a global leader in data-driven medicine focused on enabling healthcare institutions to leverage artificial intelligence and data analytics to enhance clinical diagnosis. The company's main purpose is to democratize data-driven m..
>Volltext.. |
| 316.03 Mio. EUR |
| 309.84 Mio. EUR |
| 66.94 Mio. EUR |
| -52.32 Mio. EUR |
| -68.44 Mio. EUR |
| -1.01 EUR |
| 54.6 Mio. EUR |
| 60.89 Mio. EUR |
| -34.22 Mio. EUR |
| 1.39 |
| 4.5% |
| -11.42% |
| - |
| - |
| - |
| SOPHIA GENETICS, SOPHIA GENETIC |
| 04.04.26 |
|